<DOC>
	<DOCNO>NCT01103349</DOCNO>
	<brief_summary>This 6 week study assess effect BI 671800 patient asthma . It double blind , parallel arm trial test safety efficacy BI 671800 . The main objective ass effect lung function . The study also provide data pharmacokinetics BI 671800 .</brief_summary>
	<brief_title>BI671800 Asthmatic Patients Inhaled Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Montelukast</mesh_term>
	<criteria>Inclusion criterion : 1 . Signed informed consent consistent ICHGCP 2 . Three month history reversible ( 12 % 200 mL force expiratory volume one second FEV1 ) asthma ( accord GINA ) follow spirometry randomisation : FEV1 60 % 85 % . 3 . Stable inhaled corticosteroid ( iCS ) dose 3 month prior screen . 4 . Diagnosis asthma prior 40 year . 5 . Asthma Control Questionnaire ( ACQ ) least 1.5 randomisation . 6 . Male female 18 65 year . 7 . Nonsmokers exsmokers ( less 10 pack year history ) negative cotinine screen . 8 . Able perform pulmonary function test . Exclusion criterion : 1 . Significant disease asthma allergic rhinitis . 2 . Hepatic transaminase total bilirubin great 1.5 ULN . 3 . Hospitalisation asthma exacerbation asthma related intubation within 3 month . 4 . Uncontrolled asthma iCS + controller . 5 . Respiratory tract infection exacerbation within 4 week . 6 . FEV1 le 40 % , 12 puff rescue salbutamol two consecutive day , asthma exacerbation runin period . 7 . Participation another interventional study . 8 . Pregnant nursing woman . 9 . Women child bear potential use appropriate method birth control define study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>